186 related articles for article (PubMed ID: 23698300)
1. CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.
Leskowitz RM; Zhou XY; Villinger F; Fogg MH; Kaur A; Lieberman PM; Wang F; Ertl HC
J Virol; 2013 Aug; 87(15):8351-62. PubMed ID: 23698300
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.
Leskowitz R; Fogg MH; Zhou XY; Kaur A; Silveira EL; Villinger F; Lieberman PM; Wang F; Ertl HC
J Virol; 2014 May; 88(9):4721-35. PubMed ID: 24522914
[TBL] [Abstract][Full Text] [Related]
3. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.
Fogg MH; Kaur A; Cho YG; Wang F
J Virol; 2005 Oct; 79(20):12681-91. PubMed ID: 16188971
[TBL] [Abstract][Full Text] [Related]
4. The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques.
Fogg MH; Garry D; Awad A; Wang F; Kaur A
J Immunol; 2006 Mar; 176(6):3391-401. PubMed ID: 16517707
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques.
Silveira EL; Fogg MH; Leskowitz RM; Ertl HC; Wiseman RW; O'Connor DH; Lieberman P; Wang F; Villinger F
J Virol; 2013 Dec; 87(24):13904-10. PubMed ID: 24089556
[TBL] [Abstract][Full Text] [Related]
6. Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.
Sashihara J; Hoshino Y; Bowman JJ; Krogmann T; Burbelo PD; Coffield VM; Kamrud K; Cohen JI
PLoS Pathog; 2011 Oct; 7(10):e1002308. PubMed ID: 22028652
[TBL] [Abstract][Full Text] [Related]
7. Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans.
Orlova N; Wang F; Fogg MH
J Virol; 2011 Dec; 85(23):12821-4. PubMed ID: 21917961
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.
Orlova N; Fogg MH; Carville A; Wang F
Clin Vaccine Immunol; 2011 Sep; 18(9):1427-34. PubMed ID: 21734064
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.
Herrman M; Mühe J; Quink C; Wang F
J Virol; 2016 Feb; 90(3):1222-30. PubMed ID: 26559839
[TBL] [Abstract][Full Text] [Related]
10. An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.
Ohashi M; Fogg MH; Orlova N; Quink C; Wang F
PLoS Pathog; 2012 Dec; 8(12):e1003095. PubMed ID: 23300447
[TBL] [Abstract][Full Text] [Related]
11. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
Jiang H; Cho YG; Wang F
J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073
[TBL] [Abstract][Full Text] [Related]
12. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
[TBL] [Abstract][Full Text] [Related]
13. An animal model for acute and persistent Epstein-Barr virus infection.
Moghaddam A; Rosenzweig M; Lee-Parritz D; Annis B; Johnson RP; Wang F
Science; 1997 Jun; 276(5321):2030-3. PubMed ID: 9197263
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.
Kalra M; Gerdemann U; Luu JD; Ngo MC; Leen AM; Louis CU; Rooney CM; Gottschalk S
Cytotherapy; 2019 Feb; 21(2):212-223. PubMed ID: 30396848
[TBL] [Abstract][Full Text] [Related]
15. Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections.
Rao P; Jiang H; Wang F
J Clin Microbiol; 2000 Sep; 38(9):3219-25. PubMed ID: 10970361
[TBL] [Abstract][Full Text] [Related]
16. Rhesus lymphocryptovirus infection during the progression of SAIDS and SAIDS-associated lymphoma in the rhesus macaque.
Habis A; Baskin G; Simpson L; Fortgang I; Murphey-Corb M; Levy LS
AIDS Res Hum Retroviruses; 2000 Jan; 16(2):163-71. PubMed ID: 10659055
[TBL] [Abstract][Full Text] [Related]
17. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
[TBL] [Abstract][Full Text] [Related]
18. Non-human Primate Lymphocryptoviruses: Past, Present, and Future.
Mühe J; Wang F
Curr Top Microbiol Immunol; 2015; 391():385-405. PubMed ID: 26428382
[TBL] [Abstract][Full Text] [Related]
19. Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene.
Ohashi M; Orlova N; Quink C; Wang F
J Virol; 2011 Feb; 85(3):1330-9. PubMed ID: 21084476
[TBL] [Abstract][Full Text] [Related]
20. Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.
Fogg MH; Wirth LJ; Posner M; Wang F
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3318-23. PubMed ID: 19211798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
